The environmental impact of pharmaceuticals is a significant concern, as understanding their presence, spread, and harm in coastal regions remains limited. The occurrence of non-steroidal anti-inflammatory drugs (NSAIDs), namely, mefenamic acid (MFN), diclofenac (DCF) and naproxen (NPX) were studied in river waters. Four sample collections were carried out in five points in the dry and rainy seasons. Solidified floating organic drop microextraction (SFODME) coupled with high performance liquid chromatography using diode array detection (HPLC-DAD) were applied to quantify the presence of MFN, DCF and NPX in river water samples. DCF had the highest concentration (640 ng L-1), followed by NPX (410 ng L-1). MFN was not detected in any point within the used working range (limit of detection (LOD) of 0.07 µg L-1). Additionally, an assessment was conducted to evaluate the environmental risk associated with the pharmaceuticals detected in freshwater, specifically in various organisms including algae, mollusks, amphibians, fish, and cnidarians, spanning different trophic levels. The ecotoxicological assessment showed risks ranging from low to high, indicating deleterious effects on several exposed species. No high environmental risk was detected in the sampling areas. Although no immediate negative effects were detected, the potential impact on non-target species should not be disregarded.

OBJETIVO: Realizar uma comparação crítica entre a Relação Nacional de Medicamentos Essenciais (Rename, 2012) e a Lista de Medicamentos Essenciais para Crianças (LMEC, 2011) da Organização Mundial de Saúde (OMS), com relação às diferenças entre os medicamentos e as formulações listadas para crianças. MÉTODOS: Os medicamentos da LMEC foram classificados em quatro grupos: 1) não constam na Rename; 2) constam na Rename, porém sem qualquer formulação adequada para crianças; 3) listados na Rename apenas com algumas formulações; 4) constam na Rename em todas as formulações. As formulações que faltam foram analisadas por grupos terapêuticos. As alternativas presentes na Rename foram pesquisadas. RESULTADOS: Dos 261 medicamentos de interesse listados na LMEC, 30,3% não estão presentes na Rename, 11,1% estão na Rename, mas sem qualquer formulação pediátrica, e 32,3% estão presentes em algumas, mas não todas as formulações listadas na LMEC. Considerando todos os itens de formulações listados na LMEC (n = 577), 349 não constam na Rename, desses, 19,6% devido à intensidade de dosagem, e 18,5% devido à forma farmacêutica. Faltam formulações úteis específicas para cuidado neonatal, trato respiratório e sistema nervoso central, anti-infecciosos, entre outros grupos. CONCLUSÃO: A ausência de formulações adequadas à idade de medicamentos essenciais para crianças no Brasil inclui importantes grupos terapêuticos e medicamentos indispensáveis para quadros clínicos graves. Alguns desses produtos são encontrados no mercado farmacêutico brasileiro, porém não existem em unidades públicas; outros poderiam ser produzidos por laboratórios nacionais com interesse comercial ou estimulados por uma política governamental específica, como é feito em outros países.

OBJECTIVE: To perform a critical comparison between the Brazilian national essential medicines list (Rename, 2012) with the list of essential medicines for children (LEMC, 2011) of the World Health Organization (WHO), regarding the differences among drugs and formulations listed for children. METHODS: The LEMC drugs were classified into four categories: 1) absent in Rename; 2) included in Rename but without any formulation suitable for children; 3) listed in Rename only in some formulations; 4) present in Rename in all formulations. The missing formulations were analyzed by therapeutic group. Alternatives present in Rename were searched. RESULTS: From the 261 drugs of interest on the LEMC, 30.3% are absent from Rename, 11.1% are in Rename but without any pediatric formulation, and 32.2% are present in some but not all formulations listed in LEMC. Considering all formulations items listed in the LEMC (n = 577), 349 are missing from Rename, of these 19.6% due to their strength, and 18.5% due to the the dosage form. Useful formulations specific for neonatal care, respiratory tract, central nervous system, and anti-infectives, among other groups, are missing. CONCLUSIONS: The lack of age-appropriate formulations of essential medicines for children in Brazil includes important therapeutic groups and indispensable drugs for severe clinical conditions. Some of these products exist in the Brazilian pharmaceutical market, but not in public facilities; others could be produced by national laboratories with commercial interest or stimulated by a specific governmental policy, as in other countries.

Este trabalho apresenta estudo retrospectivo de 14 pacientes com mononeuropatia de nervo intercostal (MNI), obtidos dentre 5.560 exames eletromiográficos, realizados de janeiro de 1991 até junho de 2004, em nosso Hospital Universitário. MNI foi encontrada em 14 pacientes, tendo como causas prováveis intervenções cirúrgicas torácicas em 6 (43%), neuropatia por herpes-zoster em 4 (28%), provável neurite de nervo intercostal em 2 (14%), neoplasia pulmonar em 1 (7%) e radiculopatia em 1 (7%). As principais causas de MNI de nosso Serviço são similares às da literatura. Os antidepressivos tricíclicos e anticonvulsivantes foram os fármacos mais utilizados no controle da dor.

This retrospective study describes 14 cases of intercostal nerve mononeuropathy (INM) found in 5,560 electromyography (EMG) exams performed between January 1991 and June 2004 in our University Hospital. Medical charts of all patients with history of thoracic pain and EMG diagnosis of intercostal mononeuropathy were reviewed. INM was detected in 14 patients; etiology was thoracic surgery in 6 (43%), post-herpetic neuropathy in 4 (28%), probable intercostal neuritis in 2 (14%), lung neoplasia in 1 (7%), and radiculopathy in 1 (7%). From this study, trauma and infection were the main etiologies in intercostal neuropathic pain development. Tricyclic antidepressants and anticonvulsants were the most common therapeutic drugs used.

Resumo: A Faculdade de Medicina de Botucatu, dentro de um processo de reforma curricular, organizou a partir de 1989 uma ampla avaliação através de seus docentes, alunos e ex-alunos. Como resultado, integrar disciplinas, introduzir metodologias inovadoras e estender o ensino para outros níveis de atenção médica do município foram as propostas mais contundentes. No início dos anos 90, a parceria da escola com o Programa UNI contribuiu para que a proposta se concretizasse. Em 1995, foi criada a Comissão de Apoio Pedagógica (CAP) para prestar apoio pedagógico aos órgãos colegiados na implementação do novo currículo, referente às inovações metodológicas em ensino, integração de disciplinas e produção de material didático. Para somar às avaliações Já desenvolvidas, a CAP coordenou o Projeto Cinaem. Como estratégia para integração das disciplinas, membros da CAP e docentes do ciclo básico organizaram dois módulos do atual primeiro ano de Medicina, introduzindo o método de ensino baseado em problemas (PBL). A filosofia do ensino ativo, centrado no aluno, norteou a proposta.

Abstract: Since 1989, as part of a process of curricular reform, Botucatu Medical School has been conducting extensive evaluation by way of faculty members, students and alumni: The most conspicuous outcomes are decisions to integrate subjects, introduce new and innovative methodologies and extend teaching to other levels of medical care in the municipality. This program was made possible partly by a partnership set up in the early nineties between the Medical School and the UNI Program. In 1995 the Teaching Support Committee (CAP) was set up to provide teaching support to the groups involved in implementing this new curriculum, as regards innovation in teaching methodology, integration among disciplines and production of teaching materials. To complement the existing evaluations, the CAP coordinated the Cinaem Project. As a strategy for integrating displines, members of the committee and professors of the foundation course, organized two modules of the present first year of Medicine, introducing Problem Basie Learning. The proposal was informed by the notion of active student-centered learning.